Revolution Medicines to Report Financial Results for Second Quarter 2023 After Market Close on August 8, 2023
03 août 2023 16h05 HE
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers,...
Refinery Process Additives Market to Hit US$ 3,305.73 Million By 2030 | Consegic Business Intelligence
19 juil. 2023 06h00 HE
|
CONSEGIC BUSINESS INTELLIGENCE PRIVATE LIMITED
New York, July 19, 2023 (GLOBE NEWSWIRE) -- The global Refinery Process Additives Market is expected to witness significant growth at a remarkable CAGR of 6.8% during the forecast period of...
Blue Star Foods Regains Compliance with NASDAQ Minimum Bid Price Requirement
13 juil. 2023 08h30 HE
|
Blue Star Foods Corp.
Miami, FL, July 13, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an integrated Environmental, Social, and Governance (ESG)...
Blue Star Foods Granted Option to Purchase Land for RAS Expansion in South Carolina
30 juin 2023 08h30 HE
|
Blue Star Foods Corp.
Miami, FL, June 30, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an integrated Environmental, Social, and Governance (ESG)...
Blue Star Foods Strengthens Balance Sheet by Paying Off its $5 Million Asset Based Line of Credit to Zero Balance
22 juin 2023 08h30 HE
|
Blue Star Foods Corp.
Miami, FL, June 22, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an integrated Environmental, Social, and Governance (ESG)...
Blue Star Foods Corp. Announces Reverse Stock Split
20 juin 2023 12h30 HE
|
Blue Star Foods Corp.
Miami, Florida, June 20, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp. (NASDAQ:BSFC) (“Blue Star” or the “Company”), an integrated Environmental, Social, and Governance (ESG) sustainable seafood...
Revolution Medicines to Participate in Upcoming Investor Conferences
08 juin 2023 16h05 HE
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Revolution Medicines to Participate in TD Cowen 4th Annual Oncology Innovation Summit
24 mai 2023 16h05 HE
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Blue Star Foods Reports $1.9 Million Revenue for First Quarter Ended March 31, 2023
23 mai 2023 08h30 HE
|
Blue Star Foods Corp.
Miami, FL, May 23, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an integrated Environmental, Social, and Governance (“ESG”)...
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress
08 mai 2023 16h02 HE
|
Revolution Medicines, Inc.
First Wave of Investigational RAS(ON) Inhibitors – RMC-6236 (RASMULTI), RMC-6291 (KRASG12C) and RMC-9805 (KRASG12D) – progressing on plan Appointment of chief medical officer and key leaders across...